Search
Prothipendyl
go.drugbank.com/drugs/DB12958InvestigationalProthipendyl has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders.
Products: Dominal forte 80 mg - Filmtabletten, DOMINAL FORTE 80MGIron
go.drugbank.com/drugs/DB01592ApprovedInvestigationalIt is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems.
Mixtures: FENYSOL-Z 40 MG + 15 MG/5 ML ŞURUP, 100 ML, FERRO SANOL COMP 30 MG/0,5 MG/2,5 MCG KAPSÜL, 30 ADETInternational brands: Ed-In-SolEnzalutamide
go.drugbank.com/drugs/DB08899ApprovedInvestigational[L40639] It is a second-generation antiandrogen agent that the FDA approved on August 31, 2012.
Products: XTANDI 40 MG, XTANDI ® 40 MGPentaerythritol tetranitrate
go.drugbank.com/drugs/DB06154ApprovedWithdrawnIt is recognized by the FDA to be a coronary vasodilator in the treatment of heart conditions such as angina [L2395]. … It is a pentaerythritol nitrate in which all four hydroxy groups of pentaerythritol have been converted to the corresponding nitrate ester.
Products: Peritrate Sa 80mg TabPhenobarbital
go.drugbank.com/drugs/DB01174ApprovedInvestigationalIt promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
Mixtures: PIROFEN 200 MG/15 MG SUPPOZITUAR, 5 ADET, PIROFEN 200 MG/15 MG SUPPOZITUAR, 50 ADETProducts: Barbilixir Elx 4mg/ml, FENOBARBITAL TABLETAS 50 MG.Terconazole
go.drugbank.com/drugs/DB00251ApprovedIt is classified as a _triazole ketal derivative_.[A178096] Terconazole was initially approved by the FDA in 1987.
Products: FUNGISTAT OVULOS DE 80 MG., Terazol 3 Vaginal Ovules 80mgKraurosis Vulvae
go.drugbank.com/conditions/DBCOND0114418Synonyms: Lichen sclerosus et atrophicus, Lichen sclerosus et atropicusIxekizumab
go.drugbank.com/drugs/DB11569ApprovedInvestigationalIt is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. … Ixekizumab is a humanized immunoglobulin G subclass 4 (IgG4) monoclonal antibody (mAb) against interleukin-17A (IL-17A) and prevents it from interacting with the IL-17A receptor.
Products: Taltz 80 mg solution for injection in pre-filled pen, TALTZ SOLUTION FOR INJECTION IN PRE-FILLED PEN 80 mg/mlBeractant
go.drugbank.com/drugs/DB06761ApprovedThe final composition provides 25 mg/mL phospholipids (including 11.0-15.5 mg/mL disaturated phosphatidylcholine), 0.5-1.75 mg/mL triglycerides, 1.4-3.5 mg/mL free fatty acids, and less than 1.0 mg/mL … It is suspended in 0.9% sodium chloride solution, and heat-sterilized.
Products: SURVANTA 4ML, Alveofact 45 mg/ml Pulver und Lösungsmittel zur Herstellung einer Suspension zur endotracheopulmonalen InstillationUstekinumab
go.drugbank.com/drugs/DB05679ApprovedInvestigational[L64773] The FDA approved it for adults with moderately to severely active ulcerative colitis in October 2019. … [L64773] It is used to treat plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis.[L64773] Ustekinumab was first authorized in the European Union on 16 January 2009.
Products: STELARA 130 MG, STELARA® 90 MG/ML